Performance Comparison of Five SARS-CoV-2 Antibody Assays for Seroprevalence Studies.

Younhee Park Ki Ho Hong Su Kyung Lee Jungwon Hyun Eun Jee Oh Jaehyeon Lee Hyukmin Lee Sang Hoon Song Seung-Jung Kee Gye Cheol KwonSu Hwan KimHyeon-Nam Do Ah-Ra Kim June-Woo Lee Sung Soon Kim Hyun Soo Kim

Published in: Annals of laboratory medicine (2021)

The prevalence of COVID-19 in Korea is considered to be exceptionally low at present; thus, we recommend using a combination of two or more SARS-CoV-2 antibody assays rather than a single assay. These results could help select SARS-CoV-2 antibody assays for COVID-19 seroprevalence studies in Korea.

Keyphrases

sars cov
high throughput
respiratory syndrome coronavirus
case control
risk factors
single cell
clinical evaluation